KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash & Current Investments: 2017-2025

Historic Cash & Current Investments for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $232.4 million.

  • Twist Bioscience's Cash & Current Investments fell 15.90% to $232.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 13.59%. This contributed to the annual value of $232.4 million for FY2025, which is 15.90% down from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Cash & Current Investments is $232.4 million, which was down 15.90% from $276.4 million recorded in FY2024.
  • Twist Bioscience's 5-year Cash & Current Investments high stood at $505.0 million for FY2022, and its period low was $232.4 million during FY2025.
  • For the 3-year period, Twist Bioscience's Cash & Current Investments averaged around $281.8 million, with its median value being $276.4 million (2024).
  • In the last 5 years, Twist Bioscience's Cash & Current Investments surged by 64.78% in 2021 and then crashed by 33.38% in 2023.
  • Twist Bioscience's Cash & Current Investments (Yearly) stood at $477.9 million in 2021, then grew by 5.67% to $505.0 million in 2022, then slumped by 33.38% to $336.4 million in 2023, then dropped by 17.84% to $276.4 million in 2024, then declined by 15.90% to $232.4 million in 2025.